Typical achondroplasia secondary to a unique insertional variant of FGFR3 with in vitro demonstration of its effect on FGFR3 function

Am J Med Genet A. 2021 Mar;185(3):798-805. doi: 10.1002/ajmg.a.62043. Epub 2020 Dec 2.

Abstract

We describe an individual in whom clinical and radiographic features are typical for achondroplasia, but in whom the common variants of FGFR3 that result in achondroplasia are absent. Whole exome sequencing demonstrated a novel, de novo 6 base pair tandem duplication in FGFR3 that results in the insertion of Ser-Phe after position Leu324. in vitro studies showed that this variant results in aberrant dimerization, excessive spontaneous phosphorylation of FGFR3 dimers and excessive, ligand-independent tyrosine kinase activity. Together, these data suggest that this variant leads to constitutive disulfide bond-mediated dimerization, and that this, surprisingly, occurs to an extent similar to the neonatal lethal thanatophoric dysplasia type I Ser249Cys variant.

Keywords: achondroplasia; fibroblast growth factor receptor 3; in vitro functional studies.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Achondroplasia / genetics
  • Achondroplasia / metabolism
  • Achondroplasia / pathology*
  • Adolescent
  • Adult
  • Female
  • Humans
  • Male
  • Mutation*
  • Phosphorylation
  • Prognosis
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics*
  • Receptor, Fibroblast Growth Factor, Type 3 / metabolism*
  • Signal Transduction

Substances

  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3